fda warning bpc 157 unapproved drug 2024 warning letter The U.S. Food and Administration is moving toward allowing compounding pharmacies ⁠to produce more than a dozen injectable peptides that were banned because of ⁠potentially significant safety risks, the New York FDA to weigh easing limits

Important Notes Practical points that keep daily administration of the blend safe and consistent

Regulatory and safety status: TA-1 is pending FDA review and not currently approved for use in humans

However, excessive alcohol consumption can result in folate-deficient anaemia

Storage Guidelines Immediately refrigerate at 28C after reconstitution Store upright to minimize stopper contact with solution Protect from light wrap vial in aluminum foil or store in opaque container Do NOT freeze reconstituted solutions ice crystal formation can denature the peptide Use within 2128 days of reconstitution (DAC version) Always swab the stopper with alcohol before each withdrawal Use a fresh sterile needle for each withdrawal to prevent coring and contamination Label the vial with: compound name, concentration, reconstitution date, and expiration date If you need to store reconstituted CJC-1295 DAC for longer than 28 days, aliquot into single-use volumes and flash-freeze at -20C